These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 17892353)
1. Biomarker validation: movement towards personalized medicine. Zhang X Expert Rev Mol Diagn; 2007 Sep; 7(5):469-71. PubMed ID: 17892353 [No Abstract] [Full Text] [Related]
2. Development and validation of new biomarkers: major opportunities for health-care scientists. Sturgeon C; Selby P Ann Clin Biochem; 2010 Nov; 47(Pt 6):499-502. PubMed ID: 21057049 [No Abstract] [Full Text] [Related]
3. Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Zhang J; Lang HP; Huber F; Bietsch A; Grange W; Certa U; McKendry R; Güntherodt HJ; Hegner M; Gerber Ch Nat Nanotechnol; 2006 Dec; 1(3):214-20. PubMed ID: 18654189 [TBL] [Abstract][Full Text] [Related]
4. Tissue microarrays: emerging standard for biomarker validation. Hassan S; Ferrario C; Mamo A; Basik M Curr Opin Biotechnol; 2008 Feb; 19(1):19-25. PubMed ID: 18053705 [TBL] [Abstract][Full Text] [Related]
5. Advanced proteomic technologies for cancer biomarker discovery. Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940 [TBL] [Abstract][Full Text] [Related]
6. [GENERAL AND PERSONALIZED APPROACH OF BIOMARKERS]. Cavalier E Rev Med Liege; 2015; 70(5-6):257-61. PubMed ID: 26285449 [TBL] [Abstract][Full Text] [Related]
7. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia. Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325 [TBL] [Abstract][Full Text] [Related]
8. Progress toward personalized medicine for age-related macular degeneration. Moroi SE; Heckenlively JR Ophthalmology; 2008 Jun; 115(6):925-6. PubMed ID: 18519068 [No Abstract] [Full Text] [Related]
9. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368 [TBL] [Abstract][Full Text] [Related]
11. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry. Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144 [TBL] [Abstract][Full Text] [Related]
12. Use of ex vivo systems for biomarker discovery. Lavallie ER; Dorner AJ; Burczynski ME Curr Opin Pharmacol; 2008 Oct; 8(5):647-53. PubMed ID: 18771752 [TBL] [Abstract][Full Text] [Related]
13. A fast modified protocol for random-access ultra-high density whole-genome scan: a tool for personalized genomic medicine, positional mapping, and cytogenetic analysis. Lau KC; Mak CM; Leung KY; Tsoi TH; Tang HY; Lee P; Lam CW Clin Chim Acta; 2009 Aug; 406(1-2):31-5. PubMed ID: 19445911 [TBL] [Abstract][Full Text] [Related]
14. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis. Lee JW; Hall M J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585 [TBL] [Abstract][Full Text] [Related]
15. Prognosis guarded: the crisis in American primary care medicine. Wulfers M Mo Med; 2008; 105(6):471, 473-4. PubMed ID: 19052006 [No Abstract] [Full Text] [Related]